Ludovic Brellier
CIK: 0002132959
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVTR
Avantor, Inc.
Officer
Discretionary Trading P&L
Holdings
About Brellier Ludovic
Brellier Ludovic (SEC CIK 0002132959) files insider reports with the SEC as EVP, Bioscience & Medtech of Avantor, Inc. (AVTR).
Signal8 holds 2 ownership filings by Brellier Ludovic (1 Form 3, 1 Form 4), filed on May 5, 2026. Those filings report 1 transaction, the latest on May 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Brellier Ludovic's filings is in RADNOR, PA.
Recent filings by Brellier Ludovic
- May 1, 2026: Grant or award of AVTR shares (Form 4, code A).
Other insiders filing for Avantor, Inc. (AVTR)
- Garner Todd W, EVP and CFO
- Ligner Emmanuel, President and CEO
- Hankamer Brittany, EVP, Chief HR Officer
- Eck Steven W, SVP & Chief Accounting Officer
- Sokenu Claudius, EVP, Chief Legal & Compliance
- Walker Corey, President, VWR Dist. & Servs.